Humana Inc. (HUM) Q1 2026 (USD): EPS 10.31 (exp. 10.21), Revenue -- (exp. 39.37bln); revises GAAP FY EPS guidance to "at least" 8.36 (prev. "at least" 8.89), affirms Adj. EPS guidance of "at least 9.00"
- Guides initial FY26 Revenue "at least" 160bln (exp. 162bln).
Context
Humana Inc. reported a Q1 EPS beat with $10.31 vs. $10.21 expected, although it revised down its annual GAAP EPS guidance to a range of "at least" $8.36, indicating potential challenges. The reaffirmed adjusted EPS guidance of "at least" $9.00 and initial revenue guidance suggest a cautious outlook, hinting at lower growth expectations. This mixed performance may lead to volatility in HUM's stock and could influence sentiment in the managed care sector.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#HUMANA INC#HUM.US#FOREX#EQUITIES#METALS#EU SESSION#MANAGED HEALTH CARE#METALS & MINING#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#HUM#DXY#US EQUITIES